Announcements Trials

Browse Landscape

Phase

Status

Unknown 3 Completed 3 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Thrombosis 1 Sleep Initiation and Maintenance Disorders 1 Sarcoma 1 Resectable Lung Non-Small Cell Carcinoma 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms 1 Multiple Myeloma 1 Movement Disorders 1 Motor Activity 1 Lymphoma, B-Cell 1 Lymphedema 1 Low Anterior Resection Syndrome 1 Health Education 1 Breast Neoplasms 1 Breast Cancer Lymphedema 1

Interventions

pembrolizumab 38 Blood Specimen Collection 38 Bevacizumab 22 Surveys and Questionnaires 18 Standard of Care 18 Radiotherapy 17 Exercise 17 Carboplatin 17 Nivolumab 15 atezolizumab 14 Paclitaxel 14 Cisplatin 14 Drug Therapy 13 Fluorouracil 12 Cyclophosphamide 12 Cetuximab 11 Trastuzumab 10 Pemetrexed 10 Leucovorin 10 Docetaxel 10 Dexamethasone 10 Oxaliplatin 9 Biopsy 9 pertuzumab 8 olaparib 8 Temozolomide 8 Panitumumab 8 Observation 8 Irinotecan 8 abemaciclib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms × Physical Therapy Modalities × Clear all

NCT06768918 2026-03-12

AMBeR eRehab

Zealand University Hospital

Phase NA Recruiting

Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡